Dr Amal Roy Chaudhary is the Director of Radiation Oncology at Fortis Hospital, Gurgaon, and his expertise is backed by his long and distinguished career, as well as his education.
He attended a reputed medical college and got his medical degree there. Then he went for a specialized residency in radiation oncology.
Dr. Chaudhary further improved his competence through fellowships that focused on advanced radiation methods and oncology research both in the country and abroad.
His career is characterized by a dedication to combining modern cancer therapy technologies with patient-driven care.
Dr Chaudhary is known for his competence in the use of modern radiation treatments, including IMRT (Intensity-Modulated Radiation Therapy) and IGRT (Image-Guided Radiation Therapy), which are integral for the treatment of advanced cancers with high precision.
His hands-on approach to clinical trials and research, along with continuous education at international oncology conferences, guarantees the latest advances in oncological science are incorporated into his practice. This means his patients have the best possible outcomes.
Ranked No. 2 in Delhi NCR’s Best Private Hospitals by The Week Magazine Survey, 2019 India's 1st robot-assisted Joint Replacement Surgery JCI & NABH Accredited Hospital.
Founded in 2013, Fortis Memorial Research Institute (FMRI) Hospital Gurgaon is a multi-super specialty hospital equipped with world-class infrastructure and highly qualified medical professionals, including super sub-specialists
Achieved rank 2 in a global study of ‘30 Most Technologically Advanced Hospitals in the World'
Top specialties of the hospital include cardiac sciences, gastroenterology and hepatobiliary sciences, hematology, nephrology, neurology, oncology
A flagship hospital of the extended Fortis network of hospitals, FMRI has set new benchmarks as a leading adopter of new technology and excellence in clinical care
At a national level, FMRI operates the second-largest program for bone marrow transplants, performing over 200 transplants in the last year
International patients comprise approximately 22 percent of the total patient volume, and can avail of dedicated features such as translators, prayer rooms, money exchange, and international patient lounges
Fortis Memorial Research Institute is accredited by the Joint Commission International (JCI), the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and the National Accreditation Board for Testing and Calibration Laboratories (NABL)
